Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This approach (Figure 1A) revealed that of all 41 analyzed GSC lines ~50 percent show a significant reduction of sphere-forming potential after treatment with 50 nM calcitriol (responders).

Source: 3.1. Calcitriol Reduces Sphere Formation of GSCs. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Laboratory / cell research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D3, calcitriol (1α,25(OH)2-vitamin D3) can block stemness in a subset of cell lines and reduce tumor growth.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

Study design awaiting verification · Cancers · 2023

Original publication title

Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

Sarah Rehbein; Anna-Lena Possmayer; Süleyman Bozkurt; Catharina Lotsch; Julia Gerstmeier; Michael Burger; Stefan Momma; Claudia Maletzki; Carl Friedrich Classen; Thomas M. Freiman; Daniel Dubinski; Katrin Lamszus; Brett W. Stringer; Christel Herold-Mende; Christian Münch; Donat Kögel; Benedikt Linder

© 2023 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Simple Summary

Glioblastoma is one of the worst cancer types and the most common cancer originating within the brain. Patients afflicted by glioblastoma suffer from poor prognosis, a lack of specific therapies and frequent tumor recurrences. Many researchers are confident that glioblastoma cells can display traits of stem cells and that these attributes lead to an aggressive growth and high rate of recurrence. Based on our previous work that demonstrates that the “sun hormone” vitamin D3 can block these stem cell traits, we have now gained additional insights into the effects of the active form of vitamin D3, calcitriol.

We can show that specific gene variants of the vitamin D3 receptor might be responsible for the sensitivity towards calcitriol and that sensitive cells are blocked in their stemness attributes as well as migratory potential.

Source: Simple Summary

Abstract: Abstract

Glioblastoma is the most common primary brain cancer in adults and represents one of the worst cancer diagnoses for patients. Suffering from a poor prognosis and limited treatment options, tumor recurrences are virtually inevitable. Additionally, treatment resistance is very common for this disease and worsens the prognosis. These and other factors are hypothesized to be largely due to the fact that glioblastoma cells are known to be able to obtain stem-like traits, thereby driving these phenotypes. Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D3, calcitriol (1α,25(OH)2-vitamin D3) can block stemness in a subset of cell lines and reduce tumor growth.

Here, we expanded our cell panel to over 40 different cultures and can show that, while half of the tested cell lines are sensitive, a quarter can be classified as high responders. Using genetic and proteomic analysis, we further determined that treatment success can be partially explained by specific polymorphism of the vitamin D3 receptor and that high responders display a proteome suggestive of blockade of stemness, as well as migratory potential.

Source: Abstract
Authors’ abstract

Simple Summary

Glioblastoma is one of the worst cancer types and the most common cancer originating within the brain. Patients afflicted by glioblastoma suffer from poor prognosis, a lack of specific therapies and frequent tumor recurrences. Many researchers are confident that glioblastoma cells can display traits of stem cells and that these attributes lead to an aggressive growth and high rate of recurrence. Based on our previous work that demonstrates that the “sun hormone” vitamin D3 can block these stem cell traits, we have now gained additional insights into the effects of the active form of vitamin D3, calcitriol.

We can show that specific gene variants of the vitamin D3 receptor might be responsible for the sensitivity towards calcitriol and that sensitive cells are blocked in their stemness attributes as well as migratory potential.

Abstract

Glioblastoma is the most common primary brain cancer in adults and represents one of the worst cancer diagnoses for patients. Suffering from a poor prognosis and limited treatment options, tumor recurrences are virtually inevitable. Additionally, treatment resistance is very common for this disease and worsens the prognosis. These and other factors are hypothesized to be largely due to the fact that glioblastoma cells are known to be able to obtain stem-like traits, thereby driving these phenotypes. Recently, we have shown that the in vitro and ex vivo treatment of glioblastoma stem-like cells with the hormonally active form of vitamin D3, calcitriol (1α,25(OH)2-vitamin D3) can block stemness in a subset of cell lines and reduce tumor growth.

Here, we expanded our cell panel to over 40 different cultures and can show that, while half of the tested cell lines are sensitive, a quarter can be classified as high responders. Using genetic and proteomic analysis, we further determined that treatment success can be partially explained by specific polymorphism of the vitamin D3 receptor and that high responders display a proteome suggestive of blockade of stemness, as well as migratory potential.

Publication and source details

Original title: Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells

Sarah Rehbein; Anna-Lena Possmayer; Süleyman Bozkurt; Catharina Lotsch; Julia Gerstmeier; Michael Burger; Stefan Momma; Claudia Maletzki; Carl Friedrich Classen; Thomas M. Freiman; Daniel Dubinski; Katrin Lamszus; Brett W. Stringer; Christel Herold-Mende; Christian Münch; Donat Kögel; Benedikt Linder

Cancers · 2023

* Correspondence: linder@med.uni-frankfurt.de
†

These authors contributed equally to this work.

© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This study received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:55:59.711161+00:00

DOI: 10.3390/cancers15215249 · PMC10648216